MetaCap

Surgery Partners Inc. (SGRY)

NASDAQ: SGRYHealth CareHospital/Nursing ManagementUSD

26.78+0.09 (+0.34%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SGRY stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$0.67
52-week range
11.41 – 27.23
Day range
26.64 – 26.96
Volume / Avg
1.11M / 3.87M
Beta
—

52-week range

$11.41$27.23

SGRY stock today

Surgery Partners (SGRY) closed at $26.78 on Nov 20, up 0.34% (+$0.09), versus the S&P 500's 3.70% decline. Trading was light, with 1.11M shares changing hands, about 29% of the average daily volume. Shares are 1.6% below their 52-week high of $27.23, set on Nov 9, 2026 and 134.7% above the 52-week low of $11.41, near the top of the past year's range.

SGRY is up 73.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 69.1%. Surgery Partners has posted a net loss over the last twelve months (EPS of -$0.67), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Surgery Partners

Company profile

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services.

Industry
Hospital/Nursing Management
CEO
Mr. J. Eric Evans
Headquarters
Brentwood, TN
Employees
16,000
IPO year
2015

Financial highlights

Full financials

In fiscal 2025, Surgery Partners generated $3.31 billion in revenue, up 6.2% from fiscal 2024, its 11th consecutive year of revenue growth. Surgery Partners reported a net loss of $77.9 million, compared with a loss of $168.1 million a year earlier. Operating margin was 11.8%.

Surgery Partners annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$3.31B$3.11B$2.74B$2.54B$2.23B
Growth+6.24%+13.52%+8.03%+14.12%+19.62%
Net income$-77.90M$-168.10M$-11.90M$-54.60M$-70.90M
EPS (diluted)$-0.61$-1.33$-0.09$-0.59$-1.12

Analyst forecast

Forecast

Consensus (7 analysts)

hold

Avg. price target

$24.40-8.89%

  • Strong buy 0
  • Buy 0
  • Hold 7
  • Sell 0
  • Strong sell 0

Target range

Low $23.50High $25.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 9, 2026
EPS actual vs est.
$-0.16 vs $-0.13
Surprise
-23.08%

SGRY news

All SGRY news

Surgery Partners peers

Health Care sector
SGRY peer companies
CompanyPrice% ChgMarket capCompare
NHCNational HealthCare Corporation190.77+1.18%$2.99Bvs SGRY
MDPediatrix Medical Group Inc.30.22+0.94%$2.36Bvs SGRY
BKDBrookdale Senior Living Inc.8.86+1.96%$2.12Bvs SGRY
ARDTArdent Health Inc.15.08+4.00%$2.10Bvs SGRY
HCSGHealthcare Services Group Inc.24.72-0.20%$1.67Bvs SGRY
SNDASonida Senior Living Inc.31.47-0.57%$1.55Bvs SGRY
CYHCommunity Health Systems Inc.1.62+0.62%$228.46Mvs SGRY
PACSPACS Group Inc.43.67+1.49%$6.93Bvs SGRY

Indexes, lists and sector

Surgery Partners stock FAQ

What is Surgery Partners's stock price today?

SGRY last traded at $26.78 as of Nov 20, 4:00 PM EST, up 0.34% on the day. Prices are delayed at least 15 minutes.

Who is Surgery Partners's CEO?

Mr. J. Eric Evans is the chief executive officer of Surgery Partners Inc., which has about 16,000 employees.

What is the SGRY 52-week high?

The 52-week high for SGRY is $27.23 and the 52-week low is $11.41. The stock is currently 1.6% below its high.

Compare SGRY